nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach
|
Rotolo, F. |
|
|
25 |
11 |
p. 2162-2166 |
artikel |
2 |
Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors
|
Yoo, C. |
|
|
25 |
11 |
p. 2272-2277 |
artikel |
3 |
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer
|
Novello, S. |
|
|
25 |
11 |
p. 2156-2162 |
artikel |
4 |
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma
|
Selle, F. |
|
|
25 |
11 |
p. 2191-2196 |
artikel |
5 |
Association between treatment toxicity and outcomes in oncology clinical trials
|
Abola, M.V. |
|
|
25 |
11 |
p. 2284-2289 |
artikel |
6 |
A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
|
Chung, C.H. |
|
|
25 |
11 |
p. 2230-2236 |
artikel |
7 |
Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign
|
Reich, M. |
|
|
25 |
11 |
p. 2115-2124 |
artikel |
8 |
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma †
|
Gerrie, A.S. |
|
|
25 |
11 |
p. 2218-2223 |
artikel |
9 |
Editorial board
|
|
|
|
25 |
11 |
p. ii-iii |
artikel |
10 |
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer
|
Reijm, E.A. |
|
|
25 |
11 |
p. 2185-2190 |
artikel |
11 |
Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types
|
Dal Maso, L. |
|
|
25 |
11 |
p. 2251-2260 |
artikel |
12 |
Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults
|
Suh, B. |
|
|
25 |
11 |
p. 2260-2266 |
artikel |
13 |
MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling
|
Zhang, J.X. |
|
|
25 |
11 |
p. 2196-2204 |
artikel |
14 |
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
|
Tandstad, T. |
|
|
25 |
11 |
p. 2167-2172 |
artikel |
15 |
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study
|
Borg, C. |
|
|
25 |
11 |
p. 2205-2210 |
artikel |
16 |
PD-L1 expression in nonclear-cell renal cell carcinoma
|
Choueiri, T.K. |
|
|
25 |
11 |
p. 2178-2184 |
artikel |
17 |
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
|
Abramson, J.S. |
|
|
25 |
11 |
p. 2211-2217 |
artikel |
18 |
Pharmacogenomics in NSCLC: mostly unsexy but desperately needed
|
Besse, B. |
|
|
25 |
11 |
p. 2099-2100 |
artikel |
19 |
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
|
Soria, J.-C. |
|
|
25 |
11 |
p. 2244-2251 |
artikel |
20 |
Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era
|
Vaidya, R. |
|
|
25 |
11 |
p. 2124-2133 |
artikel |
21 |
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
|
Aparicio, J. |
|
|
25 |
11 |
p. 2173-2178 |
artikel |
22 |
Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life
|
Steindorf, K. |
|
|
25 |
11 |
p. 2237-2243 |
artikel |
23 |
Reply to the letter to the editor ‘The link between type 2 diabetes and pancreatic adenocarcinoma is yet to be established’ by Rahman and Meeran
|
Bosetti, C. |
|
|
25 |
11 |
p. 2290-2291 |
artikel |
24 |
Response to chemotherapy is not related to chromosome instability in synovial sarcoma
|
Chakiba, C. |
|
|
25 |
11 |
p. 2267-2271 |
artikel |
25 |
Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force
|
Kunkler, I.H. |
|
|
25 |
11 |
p. 2134-2146 |
artikel |
26 |
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
|
Lebbé, C. |
|
|
25 |
11 |
p. 2277-2284 |
artikel |
27 |
Table of Contents
|
|
|
|
25 |
11 |
p. iv-vi |
artikel |
28 |
The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck
|
Psyrri, A. |
|
|
25 |
11 |
p. 2101-2115 |
artikel |
29 |
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party †
|
El-Najjar, I. |
|
|
25 |
11 |
p. 2224-2229 |
artikel |
30 |
The link between type 2 diabetes and pancreatic adenocarcinoma is yet to be established
|
Rahman, A. |
|
|
25 |
11 |
p. 2290 |
artikel |
31 |
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies † † These studies have previously been presented in part at the ASCO 2013 Annual Meeting, the ESMO-ECCO 2013 Annual Meeting and the IASLC 2013 World Conference on Lung Cancer
|
Moran, T. |
|
|
25 |
11 |
p. 2147-2155 |
artikel |